Clinical Trials Browser

Leukemia, Prolymphocytic, T-Cell × fludarabine × Clear all

Lymphoma, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04526795 2024-12-12

Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

Phase 1 Terminated

19 enrolled

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04823091 2022-03-16

Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies

Phase 1 Unknown

24 enrolled

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell

NCT01186640 2022-01-05

Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)

Phase 2 Completed

16 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Prolymphocytic, T-Cell

Clinical Trials

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies

Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)